The anti-neoplastic effects of coumarin: An emerging concept

Cytotechnology

Volumn 65, Issue 5, 2013, Pages 787-788

  Kapoor, Shailendra ^a  

^a not available   (United States)

Author keywords

Breast cancer; Coumarin; Prostate cancer

Indexed keywords

COUMARIN; PROTEIN BCL 2;

ANTINEOPLASTIC ACTIVITY; CANCER CELL; LETTER; LYMPHEDEMA; PROTEIN EXPRESSION; QUALITY OF LIFE;

EID: 84887086534     PISSN: 09209069     EISSN: 15730778     Source Type: Journal    
DOI: 10.1007/s10616-013-9538-6     Document Type: Letter

References (5)

1. Burgos A, Alcaide A, Alcoba C, Azcona JM, Garrido J, Lorente C, Moreno E, Murillo E, Olsina-Pavia J, Olsina-Kissler J, Samaniego E, Serra M (1999) Comparative study of the clinical efficacy of two different coumarin dosages in the management of arm lymphedema after treatment for breast cancer. Lymphology 32:3-10 (Pubitemid 29187718)
2. Liu X, Chen L, Sun F, Zhang G (2012) Enhanced suppression of proliferation and migration in highly-metastatic lung cancer cells by combination of valproic acid and coumarin-3-carboxylic acid and its molecular mechanisms of action. Cytotechnology. doi: 10.1007/s10616-012-9513-7
3. Marshall ME, Butler K, Cantrell J, Wiseman C, Mendelsohn L (1989) Treatment of advanced malignant melanoma with coumarin and cimetidine: a pilot study. Cancer Chemother Pharmacol 24:65-66 (Pubitemid 19139994)
4. Musa MA, Badisa VL, Latinwo LM, Patterson TA, Owens MA (2012) Coumarin-based benzopyranone derivatives induced apoptosis in human lung (A549) cancer cells. Anticancer Res 32:4271-4276
5. von Angerer E, Kager M, Maucher A (1994) Antitumour activity of coumarin in prostate and mammary cancer models. J Cancer Res Clin Oncol 120:S14-S16